Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
IntroductionMeaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE)...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-07-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1176200/full |
| _version_ | 1797789211359707136 |
|---|---|
| author | Ivett Jakab Ivett Jakab Maria Dimitrova François Houÿez Tamás Bereczky Miroslava Fövényes Zorana Maravic Ivica Belina Christian Andriciuc Krisztina Tóth Krisztina Tóth Oresta Piniazhko Rok Hren Rok Hren Iñaki Gutierrez-Ibarluzea Marcin Czech Tomas Tesar Maciej Niewada László Lorenzovici László Lorenzovici Maria Kamusheva Manoela Manova Manoela Manova Alexandra Savova Alexandra Savova Zornitsa Mitkova Konstantin Tachkov Bertalan Németh Zsuzsanna Ida Petykó Zsuzsanna Ida Petykó Dalia Dawoud Diana Delnoij Saskia Knies Wim Goettsch Wim Goettsch Zoltán Kaló Zoltán Kaló |
| author_facet | Ivett Jakab Ivett Jakab Maria Dimitrova François Houÿez Tamás Bereczky Miroslava Fövényes Zorana Maravic Ivica Belina Christian Andriciuc Krisztina Tóth Krisztina Tóth Oresta Piniazhko Rok Hren Rok Hren Iñaki Gutierrez-Ibarluzea Marcin Czech Tomas Tesar Maciej Niewada László Lorenzovici László Lorenzovici Maria Kamusheva Manoela Manova Manoela Manova Alexandra Savova Alexandra Savova Zornitsa Mitkova Konstantin Tachkov Bertalan Németh Zsuzsanna Ida Petykó Zsuzsanna Ida Petykó Dalia Dawoud Diana Delnoij Saskia Knies Wim Goettsch Wim Goettsch Zoltán Kaló Zoltán Kaló |
| author_sort | Ivett Jakab |
| collection | DOAJ |
| description | IntroductionMeaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are generally at less advanced stages of implementing HTA, which is particularly true for patient involvement activities. As part of the Horizon2020 HTx project, this research aimed to form recommendations for critical barriers to patient involvement in HTA in CEE countries.MethodsBuilt on previous research findings on potential barriers, a prioritisation survey was conducted online with CEE stakeholders. Recommendations for prioritised barriers were formed through a face-to-face workshop by CEE stakeholders and HTx experts.ResultsA total of 105 stakeholders from 13 CEE countries completed the prioritisation survey and identified 12 of the 22 potential barriers as highly important. The workshop had 36 participants representing 9 CEE countries, and 5 Western European countries coming together to discuss solutions in order to form recommendations based on best practices, real-life experience, and transferability aspects. Stakeholder groups involved in both phases included HTA organisation representatives, payers, patients, caregivers, patient organisation representatives, patient experts, health care providers, academic and non-academic researchers, health care consultants and health technology manufacturers/providers. As a result, 12 recommendations were formed specified to the CEE region’s context, but potentially useful for a broader geographic audience.ConclusionIn this paper, we present 12 recommendations for meaningful, systematic, and sustainable patient involvement in HTA in CEE countries. Our hope is that engaging more than a hundred CEE stakeholders in the study helped to spread awareness of the importance and potential of patient involvement and that the resulting recommendations provide tangible steps for the way forward. Future studies shall focus on country-specific case studies of the implemented recommendations. |
| first_indexed | 2024-03-13T01:47:30Z |
| format | Article |
| id | doaj.art-591d4b58b631449dbc84d503029cd297 |
| institution | Directory Open Access Journal |
| issn | 2296-2565 |
| language | English |
| last_indexed | 2024-03-13T01:47:30Z |
| publishDate | 2023-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj.art-591d4b58b631449dbc84d503029cd2972023-07-03T04:48:52ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-07-011110.3389/fpubh.2023.11762001176200Recommendations for patient involvement in health technology assessment in Central and Eastern European countriesIvett Jakab0Ivett Jakab1Maria Dimitrova2François Houÿez3Tamás Bereczky4Miroslava Fövényes5Zorana Maravic6Ivica Belina7Christian Andriciuc8Krisztina Tóth9Krisztina Tóth10Oresta Piniazhko11Rok Hren12Rok Hren13Iñaki Gutierrez-Ibarluzea14Marcin Czech15Tomas Tesar16Maciej Niewada17László Lorenzovici18László Lorenzovici19Maria Kamusheva20Manoela Manova21Manoela Manova22Alexandra Savova23Alexandra Savova24Zornitsa Mitkova25Konstantin Tachkov26Bertalan Németh27Zsuzsanna Ida Petykó28Zsuzsanna Ida Petykó29Dalia Dawoud30Diana Delnoij31Saskia Knies32Wim Goettsch33Wim Goettsch34Zoltán Kaló35Zoltán Kaló36Syreon Research Institute, Budapest, HungaryPatient advocate, Budapest, HungaryFaculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaEuropean Organisation for Rare Diseases (EURORDIS), Paris, FrancePatvocates GmbH, Riemerling, GermanyLymfoma Slovensko, Bratislava, SlovakiaDigestive Cancers Europe, Brussels, BelgiumCoalition of Associations in Healthcare, Zagreb, CroatiaRomanian Federation of Diabetes Associations, Cluj Napoca, RomaniaSyreon Research Institute, Budapest, Hungary0Bridge of Health Alliance against Breast Cancer Association, Budapest, Hungary1Health Technology Assessment Department of State Expert Centre, Ministry of Health of Ukraine, Kyiv, UkraineSyreon Research Institute, Budapest, Hungary2Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia3Basque Foundation for Health Innovation and Research, Landa, Spain4Head of Pharmacoeconomic Department, Institute of Mother and Child, Warsaw, Poland5Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia6Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland7Syreon Research Romania, Tirgu Mures, Romania8Department of Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology, Targu Mures, RomaniaFaculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria9National Council on Prices and Reimbursement of Medicines, Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria9National Council on Prices and Reimbursement of Medicines, Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, Sofia, BulgariaSyreon Research Institute, Budapest, HungarySyreon Research Institute, Budapest, Hungary0Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary1Science, Policy and Research Programme, National Institute for Health and Care Excellence, London, United Kingdom2National Health Care Institute (ZIN), Diemen, Netherlands2National Health Care Institute (ZIN), Diemen, Netherlands2National Health Care Institute (ZIN), Diemen, Netherlands3WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsSyreon Research Institute, Budapest, Hungary0Centre for Health Technology Assessment, Semmelweis University, Budapest, HungaryIntroductionMeaningful patient involvement in health technology assessment (HTA) is essential in ensuring that the interests of the affected patient population, their families, and the general public are accurately reflected in coverage and reimbursement decisions. Central and Eastern European (CEE) countries are generally at less advanced stages of implementing HTA, which is particularly true for patient involvement activities. As part of the Horizon2020 HTx project, this research aimed to form recommendations for critical barriers to patient involvement in HTA in CEE countries.MethodsBuilt on previous research findings on potential barriers, a prioritisation survey was conducted online with CEE stakeholders. Recommendations for prioritised barriers were formed through a face-to-face workshop by CEE stakeholders and HTx experts.ResultsA total of 105 stakeholders from 13 CEE countries completed the prioritisation survey and identified 12 of the 22 potential barriers as highly important. The workshop had 36 participants representing 9 CEE countries, and 5 Western European countries coming together to discuss solutions in order to form recommendations based on best practices, real-life experience, and transferability aspects. Stakeholder groups involved in both phases included HTA organisation representatives, payers, patients, caregivers, patient organisation representatives, patient experts, health care providers, academic and non-academic researchers, health care consultants and health technology manufacturers/providers. As a result, 12 recommendations were formed specified to the CEE region’s context, but potentially useful for a broader geographic audience.ConclusionIn this paper, we present 12 recommendations for meaningful, systematic, and sustainable patient involvement in HTA in CEE countries. Our hope is that engaging more than a hundred CEE stakeholders in the study helped to spread awareness of the importance and potential of patient involvement and that the resulting recommendations provide tangible steps for the way forward. Future studies shall focus on country-specific case studies of the implemented recommendations.https://www.frontiersin.org/articles/10.3389/fpubh.2023.1176200/fullpatient involvementhealth technology assessmentreimbursementdecision-makingCentral and Eastern Europe countriesstakeholder perspectives |
| spellingShingle | Ivett Jakab Ivett Jakab Maria Dimitrova François Houÿez Tamás Bereczky Miroslava Fövényes Zorana Maravic Ivica Belina Christian Andriciuc Krisztina Tóth Krisztina Tóth Oresta Piniazhko Rok Hren Rok Hren Iñaki Gutierrez-Ibarluzea Marcin Czech Tomas Tesar Maciej Niewada László Lorenzovici László Lorenzovici Maria Kamusheva Manoela Manova Manoela Manova Alexandra Savova Alexandra Savova Zornitsa Mitkova Konstantin Tachkov Bertalan Németh Zsuzsanna Ida Petykó Zsuzsanna Ida Petykó Dalia Dawoud Diana Delnoij Saskia Knies Wim Goettsch Wim Goettsch Zoltán Kaló Zoltán Kaló Recommendations for patient involvement in health technology assessment in Central and Eastern European countries Frontiers in Public Health patient involvement health technology assessment reimbursement decision-making Central and Eastern Europe countries stakeholder perspectives |
| title | Recommendations for patient involvement in health technology assessment in Central and Eastern European countries |
| title_full | Recommendations for patient involvement in health technology assessment in Central and Eastern European countries |
| title_fullStr | Recommendations for patient involvement in health technology assessment in Central and Eastern European countries |
| title_full_unstemmed | Recommendations for patient involvement in health technology assessment in Central and Eastern European countries |
| title_short | Recommendations for patient involvement in health technology assessment in Central and Eastern European countries |
| title_sort | recommendations for patient involvement in health technology assessment in central and eastern european countries |
| topic | patient involvement health technology assessment reimbursement decision-making Central and Eastern Europe countries stakeholder perspectives |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1176200/full |
| work_keys_str_mv | AT ivettjakab recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT ivettjakab recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT mariadimitrova recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT francoishouyez recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT tamasbereczky recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT miroslavafovenyes recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT zoranamaravic recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT ivicabelina recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT christianandriciuc recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT krisztinatoth recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT krisztinatoth recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT orestapiniazhko recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT rokhren recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT rokhren recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT inakigutierrezibarluzea recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT marcinczech recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT tomastesar recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT maciejniewada recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT laszlolorenzovici recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT laszlolorenzovici recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT mariakamusheva recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT manoelamanova recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT manoelamanova recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT alexandrasavova recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT alexandrasavova recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT zornitsamitkova recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT konstantintachkov recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT bertalannemeth recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT zsuzsannaidapetyko recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT zsuzsannaidapetyko recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT daliadawoud recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT dianadelnoij recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT saskiaknies recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT wimgoettsch recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT wimgoettsch recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT zoltankalo recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries AT zoltankalo recommendationsforpatientinvolvementinhealthtechnologyassessmentincentralandeasterneuropeancountries |